EYES Insider Trading

Second Sight Medical Products, Inc. (EYES) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $210.0M, listed on NASDAQ, employing roughly 15 people, carrying a beta of 2.56 to the broader market. As of August 30, 2022, Second Sight Medical Products, Inc. Led by Matthew Pfeffer, public since 2014-11-19.

In the last 12 months, Second Sight Medical Products, Inc. insiders made 0 buy transactions and 0 sale transactions.

DateNameTypeSharesPriceValue
Aug 31, 2022Mendelsohn AdamD0$0.00$0
Aug 31, 2022Le TrucD0$0.00$0
Aug 31, 2022Makes BrigidD0$0.00$0
Aug 31, 2022Dwyer DonaldD0$0.00$0
Aug 31, 2022Porter Lisa EllenD0$0.00$0
Jun 15, 2022Williams GreggP-Purchase100$2.00$200
Jun 15, 2022Williams GreggP-Purchase3,700$2.00$7.4K
Jun 7, 2022Williams GreggP-Purchase3,960$2.46$9.7K
Jun 2, 2022Williams GreggP-Purchase105,162$2.34$245.7K
Jun 2, 2022Williams GreggP-Purchase132,461$2.26$299.3K

How to Read EYES Insider Activity

Net insider activity is balanced over the trailing twelve months: 0 buys against 0 sales. Balanced activity typically reflects routine compensation-related vesting and tax-driven liquidity rather than directional information signals. The transaction table above includes the filer's reporting name, transaction type, share count, per-share price, and total dollar value where computable. For options traders, insider activity is one input to event-driven sizing alongside earnings calendar, analyst-rating cluster moves, and the implied-vol surface. Form 4 filings (the dominant Section 16 reporting form) must be submitted within two business days of the transaction; clusters of buys across multiple insiders within a short window are the strongest informational pattern. SEC EDGAR carries the underlying source filings for verification and additional historical depth.

Learn how insider trading is reported and how to read the data →